Biohaven Therapeutics Ltd.
18
7
10
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
2 terminated/withdrawn out of 18 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Long-term Safety and Tolerability of BHV-7000
Role: lead
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Role: lead
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Role: lead
A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia
Role: lead
Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD)
Role: lead
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures
Role: lead
Taldefgrobep Alfa in Adults With Overweight and Obesity
Role: lead
Study of BHV-1300 in Graves' Disease
Role: lead
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
Role: lead
Study of BHV-1400 in IgA Nephropathy
Role: lead
Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine
Role: lead
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Role: lead
Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control
Role: lead
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Role: lead
BHV-7000 Acute Treatment of Bipolar Mania
Role: lead
BHV-7000 Open-Label Extension Bipolar Mania Study
Role: lead
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Role: lead
Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA).
Role: collaborator
All 18 trials loaded